Key points A 39-year-old woman with a known history of antiphospholipid syndrome (APS) presented to the emergency department with acute shortness of breath, pleuritic chest pain, and presyncope. On ...
Most clots seen in the antiphospholipid syndrome (APS) are venous; however, a proportion of clots can be arterial, leading to significant morbidity and mortality. Furthermore, arterial vascular ...
Patients with thrombotic antiphospholipid syndrome are better treated with a vitamin K antagonist, such as warfarin, rather than a direct oral anticoagulant (DOAC), a new systematic review and ...
Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...
Targeting glycolysis can help lower neutrophil extracellular trap formation in antiphospholipid syndrome. Neutrophils are an important type of white blood cell that help your immune system fight ...
Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...
Background Current diagnosis of antiphospholipid syndrome (APS) relies on antiphospholipid antibodies (aPL) testing, but false-positive aPL results and asymptomatic aPL carriers pose significant ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Preventing the first thrombosis, and better circumvention of the second, are currently the biggest ...
Antiphospholipid syndrome (APS) is an autoimmune disorder characterised by the persistent presence of antiphospholipid antibodies (aPL), which significantly increase the risk of thrombosis and adverse ...
APS is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such as ...
Some patients with lupus who possess specific antibodies are at a higher risk of thrombotic events such as a blood clot, stroke or heart attack, a new study led by Johns Hopkins Medicine researchers ...